[go: up one dir, main page]

CA2434944A1 - Proteines secretees - Google Patents

Proteines secretees Download PDF

Info

Publication number
CA2434944A1
CA2434944A1 CA002434944A CA2434944A CA2434944A1 CA 2434944 A1 CA2434944 A1 CA 2434944A1 CA 002434944 A CA002434944 A CA 002434944A CA 2434944 A CA2434944 A CA 2434944A CA 2434944 A1 CA2434944 A1 CA 2434944A1
Authority
CA
Canada
Prior art keywords
polynucleotide
polypeptide
seq
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002434944A
Other languages
English (en)
Inventor
Tom Y. Tang
Henry Yue
Ameena R. Gandhi
Monique G. Yao
Bridget A. Warren
Li Ding
Brendan M. Duggan
Yuming Xu
Junming Yang
Kavitha Thangavelu
Preeti G. Lal
Cynthia D. Honchell
Narinder K. Chawla
Sally Lee
Ernestine A. Lee
Thomas W. Richardson
Mariah R. Baughn
Vicki S. Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of CA2434944A1 publication Critical patent/CA2434944A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Cette invention concerne des protéines sécrétées humaines (SECP) et des polynucléotides qui identifient ces protéines et codent pour ces dernières. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Sont également décrites des méthodes de diagnostic, de traitement ou de prévention de troubles en rapport avec l'expression aberrante desdites SECP.
CA002434944A 2001-02-02 2002-01-28 Proteines secretees Abandoned CA2434944A1 (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US26619501P 2001-02-02 2001-02-02
US60/266,195 2001-02-02
US26792401P 2001-02-08 2001-02-08
US60/267,924 2001-02-08
US26811201P 2001-02-09 2001-02-09
US26781601P 2001-02-09 2001-02-09
US60/267,816 2001-02-09
US60/268,112 2001-02-09
US27163901P 2001-02-26 2001-02-26
US60/271,639 2001-02-26
US31781801P 2001-09-07 2001-09-07
US60/317,818 2001-09-07
US34355301P 2001-12-21 2001-12-21
US60/343,553 2001-12-21
PCT/US2002/002616 WO2002062841A2 (fr) 2001-02-02 2002-01-28 Proteines secretees

Publications (1)

Publication Number Publication Date
CA2434944A1 true CA2434944A1 (fr) 2002-08-15

Family

ID=27569522

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002434944A Abandoned CA2434944A1 (fr) 2001-02-02 2002-01-28 Proteines secretees

Country Status (4)

Country Link
EP (1) EP1355935A2 (fr)
JP (1) JP2004537273A (fr)
CA (1) CA2434944A1 (fr)
WO (1) WO2002062841A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0201808D0 (en) * 2002-01-25 2002-03-13 European Molecular Biology Lab Embl Protein
DE10213762A1 (de) * 2002-03-26 2003-10-09 Boehringer Ingelheim Int Neues costimulierendes Molekül und dessen Verwendung
JPWO2005016367A1 (ja) * 2003-08-13 2006-10-12 株式会社ロコモジェン 造血系疾患の治療用製剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
WO2002062841A2 (fr) 2002-08-15
JP2004537273A (ja) 2004-12-16
WO2002062841A3 (fr) 2003-06-05
EP1355935A2 (fr) 2003-10-29

Similar Documents

Publication Publication Date Title
EP1341812A2 (fr) Proteines secretees
WO2001098353A2 (fr) Proteines secretees
WO2002048337A2 (fr) Proteines secretees
EP1434796A2 (fr) Proteines secretees
US20030215822A1 (en) Secreted proteins
US20040248249A1 (en) Secreted proteins
US20040198651A1 (en) Secreted proteins
CA2427085A1 (fr) Proteines transmembranaires
WO2002070669A2 (fr) Proteines secretees
US20040063924A1 (en) Secreted proteins
EP1370655A2 (fr) Proteines secretees humaines
US20050069876A1 (en) Secreted proteins
CA2434944A1 (fr) Proteines secretees
EP1417224A2 (fr) Proteines secretees
WO2004094589A2 (fr) Proteines secretees
US20040087773A1 (en) Molecules for disease detection and treatment
WO2002097035A2 (fr) Proteines secretees
WO2002070709A2 (fr) Molecules de detection et de traitement de maladies
CA2431144A1 (fr) Proteines d'adhesion cellulaire
US20040082761A1 (en) Cell adhesion proteins
WO2003046196A1 (fr) Proteines secretees
WO2004085666A2 (fr) Proteines secretees
JP2004535159A (ja) 疾患検出及び治療用分子
WO2004020459A2 (fr) Proteines secretees
JP2004534506A (ja) 分泌タンパク質

Legal Events

Date Code Title Description
FZDE Dead